HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $545,853,880 | +44.1% | 4,718,246 | +28.1% | 0.57% | +47.3% |
Q2 2023 | $378,732,783 | +55.9% | 3,682,380 | +65.5% | 0.39% | +48.8% |
Q1 2023 | $242,873,389 | +2564.8% | 2,225,338 | +2678.5% | 0.26% | +2500.0% |
Q4 2022 | $9,114,242 | -64.4% | 80,090 | -80.7% | 0.01% | -67.7% |
Q3 2022 | $25,633,000 | +1249.8% | 414,178 | +1639.5% | 0.03% | +1450.0% |
Q2 2022 | $1,899,000 | -93.3% | 23,810 | -91.2% | 0.00% | -92.6% |
Q1 2022 | $28,488,000 | +81.2% | 270,774 | +85.6% | 0.03% | +107.7% |
Q4 2021 | $15,721,000 | -43.8% | 145,893 | -42.8% | 0.01% | -48.0% |
Q3 2021 | $27,959,000 | -29.7% | 255,237 | -39.9% | 0.02% | -26.5% |
Q2 2021 | $39,769,000 | -73.3% | 424,701 | -73.7% | 0.03% | -76.4% |
Q1 2021 | $148,870,000 | -11.7% | 1,617,448 | -29.8% | 0.14% | -4.6% |
Q4 2020 | $168,519,000 | -28.6% | 2,303,746 | -24.2% | 0.15% | -37.6% |
Q3 2020 | $236,117,000 | +42.9% | 3,039,613 | +2.3% | 0.24% | +22.8% |
Q2 2020 | $165,207,000 | +29.2% | 2,972,432 | -31.2% | 0.20% | -1.5% |
Q1 2020 | $127,891,000 | -31.2% | 4,317,753 | -15.9% | 0.20% | -6.1% |
Q4 2019 | $185,856,000 | +33.6% | 5,134,157 | +0.5% | 0.21% | +24.6% |
Q3 2019 | $139,141,000 | +13.4% | 5,109,826 | +0.2% | 0.17% | +11.8% |
Q2 2019 | $122,656,000 | – | 5,097,929 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |